Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation - PubMed (original) (raw)
Fluorescence endoscopy for the detection of low and high grade dysplasia in ulcerative colitis using systemic or local 5-aminolaevulinic acid sensitisation
H Messmann et al. Gut. 2003 Jul.
Abstract
Background and aims: Longstanding ulcerative colitis (UC), especially in the presence of epithelial dysplasia, is associated with an increased risk of developing cancer. As dysplasia is not visible during routine endoscopy, at least 40-50 random biopsies in four quadrants every 10 cm are recommended. Fluorescence endoscopy after sensitisation with 5-aminolaevulinic acid (5-ALA) was assessed for the detection of dysplasia in ulcerative colitis by taking optical guided biopsies. 5-ALA is converted intracellularly into the sensitiser protoporphyrin IX which accumulates selectively in neoplastic tissue allowing the detection of dysplasia by typical red fluorescence after illumination with blue light.
Methods: In 37 patients with UC, 54 examinations were performed with fluorescence endoscopy after oral (20 mg/kg) or local (either with an enema or by spraying the mucosa with a catheter) sensitisation with 5-ALA. A total of 481 biopsies of red fluorescent (n=218) and non-fluorescent (n=263) areas of the colonic mucosa were taken.
Results: Forty two biopsies in 12 patients revealed either low grade (n=40) or high grade (n=2) dysplasia. Sensitivity of fluorescence for dysplastic lesions was excellent and ranged from 87% (95% confidence interval (CI) 0.73-1.00) to 100% (95% CI 1.00-1.00) after local sensitisation, in contrast with only 43% (95% CI 0.17-0.69) after systemic administration. Specificity did not differ for both forms of local sensitisation (enema 51% (95% CI 0.44-0.57) and spray catheter 62% (95% CI 0.51-0.73)); after systemic sensitisation specificity was 73% (95% CI 0.69-0.83). Negative predictive values of non-fluorescent mucosa for exclusion of dysplasia were very high; 89% after systemic sensitisation and 98-100% after local sensitisation. Positive predictive values were 13% and 14% after local sensitisation with enema and spray catheter, and 21% after oral sensitisation with 20 mg/kg ALA. The overall number of biopsies per examination was less than five from fluorescent positive areas.
Conclusion: Fluorescence endoscopy after 5-ALA sensitisation is a possible tool to visualise dysplastic lesions in ulcerative colitis using 5-ALA sensitisation. Local sensitisation is a promising alternative approach compared with systemic administration of 5-ALA. A randomised controlled study is now indicated to compare the efficacy of endoscopic fluorescence detection with the standard technique of four quadrant random biopsies.
Figures
Figure 1
Endoscopic fluorescence images. (A, B) Comparative presentation of regular white light endoscopy (A) and fluorescence endoscopy (B) one hour after local sensitisation with enema. A biopsy from the red fluorescent area presented a flat adenoma with low grade dysplasia, as shown in (C) and (D). (C, D) Haematoxylin and eosin sections of a biopsy of a red fluorescent area showing an overview (C) (magnification 40×) and further enlargement of distorted crypts with irregular and slightly hyperchromatic nuclei (D) (magnification 125×).
Figure 2
Endoscopic fluorescence images. (A, B) Comparative presentation of regular endoscopy with white light (A) and fluorescence endoscopy (B) one hour after local sensitisation with enema. A biopsy from the red fluorescent area presented high grade dysplasia.
Similar articles
- Endoscopic fluorescence detection of low and high grade dysplasia in Barrett's oesophagus using systemic or local 5-aminolaevulinic acid sensitisation.
Endlicher E, Knuechel R, Hauser T, Szeimies RM, Schölmerich J, Messmann H. Endlicher E, et al. Gut. 2001 Mar;48(3):314-9. doi: 10.1136/gut.48.3.314. Gut. 2001. PMID: 11171819 Free PMC article. - Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization.
Messmann H, Knüchel R, Bäumler W, Holstege A, Schölmerich J. Messmann H, et al. Gastrointest Endosc. 1999 Jan;49(1):97-101. doi: 10.1016/s0016-5107(99)70453-0. Gastrointest Endosc. 1999. PMID: 9869731 - Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid.
Messmann H, Kullmann F, Wild T, Knüchel-Clarke R, Rüschoff J, Gross V, Schölmerich J, Holstege A. Messmann H, et al. Endoscopy. 1998 May;30(4):333-8. doi: 10.1055/s-2007-1001278. Endoscopy. 1998. PMID: 9689504 - 5-Aminolevulinic acid-induced protoporphyrin IX for the detection of gastrointestinal dysplasia.
Messmann H. Messmann H. Gastrointest Endosc Clin N Am. 2000 Jul;10(3):497-512. Gastrointest Endosc Clin N Am. 2000. PMID: 10899260 Review. - Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
Azizi S, Al-Rubaye H, Turki MAA, Siddiqui MRS, Shanmuganandan AP, Ehsanullah B, Brar R, Abulafi AM. Azizi S, et al. Int J Surg. 2018 Apr;52:180-188. doi: 10.1016/j.ijsu.2018.02.028. Epub 2018 Feb 17. Int J Surg. 2018. PMID: 29462738 Review.
Cited by
- Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors.
Kvorjak M, Ruffo E, Tivon Y, So V, Parikh A, Deiters A, Lohmueller J. Kvorjak M, et al. ACS Synth Biol. 2023 Oct 20;12(10):2996-3007. doi: 10.1021/acssynbio.3c00320. Epub 2023 Oct 4. ACS Synth Biol. 2023. PMID: 37791909 Free PMC article. - Conditional control of universal CAR T cells by cleavable OFF-switch adaptors.
Kvorjak M, Ruffo E, Tivon Y, So V, Parikh AB, Deiters A, Lohmueller J. Kvorjak M, et al. bioRxiv [Preprint]. 2023 May 23:2023.05.22.541664. doi: 10.1101/2023.05.22.541664. bioRxiv. 2023. PMID: 37292935 Free PMC article. Updated. Preprint. - Endoscopic visualization of cancer and dysplasia in patients with ulcerative colitis following sensitization with oral 5-aminolevulinic acid.
Kato T, Iwasaki T, Arihiro S, Saruta M. Kato T, et al. J Dig Dis. 2020 Sep;21(9):498-504. doi: 10.1111/1751-2980.12923. J Dig Dis. 2020. PMID: 32686910 Free PMC article. - Delta-Aminolevulinic Acid-Mediated Photodiagnoses in Surgical Oncology: A Historical Review of Clinical Trials.
Georges JF, Valeri A, Wang H, Brooking A, Kakareka M, Cho SS, Al-Atrache Z, Bamimore M, Osman H, Ifrach J, Yu S, Li C, Appelt D, Lee JYK, Nakaji P, Brill K, Yocom S. Georges JF, et al. Front Surg. 2019 Sep 4;6:45. doi: 10.3389/fsurg.2019.00045. eCollection 2019. Front Surg. 2019. PMID: 31555659 Free PMC article. Review. - Autofluorescence Imaging Reflects the Nuclear Enlargement of Tumor Cells as well as the Cell Proliferation Ability and Aberrant Status of the p53, Ki-67, and p16 Genes in Colon Neoplasms.
Moriichi K, Fujiya M, Kobayashi Y, Murakami Y, Iwama T, Kunogi T, Sasaki T, Ijiri M, Takahashi K, Tanaka K, Sakatani A, Ando K, Nomura Y, Ueno N, Kashima S, Ikuta K, Tanabe H, Mizukami Y, Saitoh Y, Okumura T. Moriichi K, et al. Molecules. 2019 Mar 20;24(6):1106. doi: 10.3390/molecules24061106. Molecules. 2019. PMID: 30897785 Free PMC article.
References
- Levine B. Risk of cancer in ulcerative colitis. Gastrointest Endosc 1999;49:S60–2. - PubMed
- Tytgat GNJ, Dhir V, Gopinath N. Endoscopic appearance of dysplasia and cancer in inflammatory bowel disease. Eur J Cancer 1995;31:1174–7. - PubMed
- Bond JH. Colorectal surveillance for neoplasia: an overview. Gastrointest Endosc 1999;49:S35–40. - PubMed
- Peng Q, Warloe T, Berg K, et al. Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997;79:2282–308. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials